Highview Capital Management LLC/DE/ recently filed their 13F report for the fourth quarter of 2022, which ended on 2022-12-31.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
2150 E LAKE COOK RD BUFFALO GROVE, IL 60089
As of the latest 13F report, the guru’s equity portfolio contained 106 stocks valued at a total of $164.00Mil. The top holdings were
According to GuruFocus data, these were Highview Capital Management LLC/DE/’s top five trades of the quarter.
Invesco DB US Dollar Index Bullish Fund
The guru established a new position worth 189,312 shares in ARCA:UUP, giving the stock a 4.23% weight in the equity portfolio. Shares traded for an average price of $28.98 during the quarter.
On 01/30/2023, Invesco DB US Dollar Index Bullish Fund traded for a price of $27.57 per share and a market cap of $1.47Bil. The stock has returned 6.78% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
iShares 7-10 Year Treasury Bond ETF
The guru established a new position worth 56,428 shares in NAS:IEF, giving the stock a 4.02% weight in the equity portfolio. Shares traded for an average price of $101.09 during the quarter.
On 01/30/2023, iShares 7-10 Year Treasury Bond ETF traded for a price of $98.70999999999999 per share and a market cap of $24.52Bil. The stock has returned -10.67% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
Vanguard Short-Term Corporate Bond ETF
Highview Capital Management LLC/DE/ reduced their investment in NAS:VCSH by 26,027 shares. The trade had a 1.53% impact on the equity portfolio. During the quarter, the stock traded for an average price of $75.92.
On 01/30/2023, Vanguard Short-Term Corporate Bond ETF traded for a price of $76.15000000000001 per share and a market cap of $41.77Bil. The stock has returned -3.22% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
Vertex Pharmaceuticals Inc
The guru established a new position worth 4,646 shares in NAS:VRTX, giving the stock a 1% weight in the equity portfolio. Shares traded for an average price of $287.72 during the quarter.
On 01/30/2023, Vertex Pharmaceuticals Inc traded for a price of $319.98 per share and a market cap of $82.14Bil. The stock has returned 31.55% over the past year.
GuruFocus gives the company a financial strength rating of 9 out of 10 and a profitability rating of 7 out of 10.
In terms of valuation, Vertex Pharmaceuticals Inc has a price-earnings ratio of 25.24, a price-book ratio of 6.30, a price-earnings-to-growth (PEG) ratio of 0.20, a EV-to-Ebitda ratio of 17.41 and a price-sales ratio of 9.48.
The price-to-GF Value ratio is 0.99, earning the stock a GF Value rank of 5.
SPDR Gold Shares ETF
The guru sold out of their 6,157-share investment in ARCA:GLD. Previously, the stock had a 0.8% weight in the equity portfolio. Shares traded for an average price of $160.81 during the quarter.
On 01/30/2023, SPDR Gold Shares ETF traded for a price of $178.76 per share and a market cap of $56.74Bil. The stock has returned 6.98% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
When GuruFocus covers insider information, we only track open market or the private purchase and sale of common stock with the transaction code of P or S. Therefore, all the transactions mentioned in this article are only the ones with transaction code of P or S.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
